Biotest AG operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotest AG with three other
pharmaceutical manufacturers in Europe:
FAES Farma SA
sales of 274.58 million Euro [US$313.44 million]
of which 84%
was Speciality Pharmaceuticals),
(352.17 million Euro [US$402.02 million]
of which 56%
was Europe), and
Dechra Pharmaceuticals PLC
based in the United Kingdom
(£359.28 million [US$457.68 million]
of which 63%
was European Pharmaceuticals).
During the year ended December of 2017, sales at
Biotest AG were 378.10 million Euro (US$431.62 million).
decrease of 31.6%
versus 2016, when the company's sales were 553.10 million Euro.
Contributing to the drop in overall sales was the 70.8% decline
in Plasma and Services, from 199.30 million Euro to 58.20 million Euro.
There were also decreases in sales in
Therapy (down 9.5% to 313.70 million Euro)
Other (down 11.4% to 6.20 million Euro)